Schistosomiasis is endemic in 76 countries worldwide with people infected and an estimated 779 million people at risk of infection.1 Schistosomiasis is caused by blood flukes of the genus Schistosoma (S); both S. mansoni (intestinal schistosomiasis) and S. haematobium (urogenital schistosomiasis) are endemic in Africa.2 Schistosomiasis presents a substantial public health and economic burden as it is a disease of poverty. In the drive to attain the World Health Organization (WHO) control and elimination targets, diagnosis for adequate monitoring of interventions and surveillance is critical.2,3 Recently, the WHO published the diagnostic target product profiles (TPP) for monitoring, evaluation, and surveillance of schistosomiasis control programs,4 which identifies development of diagnostic tests for S. haematobium detection as a high-risk requirement due to lack of its availability. The TPP suggests a semi-quantitative analysis, capable of providing some degree of information regarding intensity of infection, as ideal for a diagnostic test for schistosomiasis to support monitoring and evaluation.4 Currently, microscopy is the WHO reference standard for the diagnosis of schistosomiasis in resource-limited settings. For the detection of S. haematobium infection, urine samples, after filtration, sedimentation, or centrifugation, are microscopically examined for the presence of eggs.3 This method is operator dependent, costly, laborious, and time-consuming. Furthermore, it requires expertise, which means microscopy skills need to be gained and maintained, which can be an economic challenge, particularly in remote rural communities.3 There is also the risk of visual health complications among microscopists resulting from excessive workload due to the low ratio of trained microscopists to samples for analysis in endemic regions.5 Hence, a field adaptable, rapid, and easy-to-use automated diagnosis is relevant for the prompt detection of cases, which will facilitate mapping and monitoring of interventions.4 Recent advances in opto-mechanics and opto-electronics have rapidly transformed the field of biomedical optics. Optical imaging technologies, such as conventional light microscopes, are being redesigned to integrate and miniaturize portable light microscopes for use at the point of care.6 – 9 Although these technologies are readily available in high-income countries, unfortunately, nearly all schistosomiasis cases are seen in low-resource regions of low-income countries, significantly justifying the need for cost-effective and easy-to-use smart diagnostic technologies. In this work, we address these challenges by first increasing the size of the S. haematobium (SH) dataset in our previous work10 from 5198 to 12,051 images of clinical samples.11 We carry out detection and counting of S. haematobium eggs present in each image by proposing a two-stage framework consisting of a DeepLabv3 with MobilenetV3 backbone deep convolutional neural network12 trained on the SH dataset using a transfer learning approach. The second stage of our proposed framework is a refined segmentation and egg counting procedure, which adapts the region-based fitting of overlapping ellipses13 to efficiently separate the boundaries of overlapping eggs in the image. Finally, the detected isolated eggs are screened for the presence of an egg, which meets the defined boundary condition before the sample can be determined as positive/negative diagnosis. We further demonstrate the robustness and applicability of the proposed framework for field diagnoses of urogenital schistosomiasis by implementing our framework on an Edge AI system (Raspberry Pi + Coral USB accelerator) and testing 65 clinical urine samples obtained in a field settings in Nigeria. The main contributions of this work can be summarized as follows.